berotek has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pansegrouw, DF | 1 |
| Flannery, EM; Herbison, GP; Lake, DC; Print, CG; Sears, MR; Taylor, DR | 1 |
| Crescioli, S; Fabbri, LM; Saetta, M; Thiene, G | 1 |
| Lindsay, DA | 1 |
| Giovannini, M; Perri, G; Spada, E | 1 |
| Kurgan, J | 1 |
| Crompton, GK | 1 |
| Baker, MJ; Cockcroft, DW; Habbick, B; McNutt, M | 1 |
| Burak, W; Dabrowski, G; Grzeszczak, W | 1 |
| Antonicelli, L; Bonifazi, F; Cinti, B; Facchini, G; Massei, V | 1 |
| Narita, N; Yamamoto, C | 1 |
| Endoh, N; Ichinose, M; Mashito, Y; Miura, M; Shirato, K; Sugiura, H; Takahashi, T | 1 |
1 review(s) available for berotek and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
[The clinical usefulness of the combined use of inhaled beta 2-agonist and inhaled steroid in asthma].
Topics: Adrenergic beta-Agonists; Adult; Anti-Inflammatory Agents; Asthma; Beclomethasone; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Fenoterol; Humans; Procaterol | 1996 |
3 trial(s) available for berotek and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Acute resistant asthma caused by excessive beta-2-adrenoceptor agonist inhalation and reversed by inhalation of beclomethasone.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Asthma; Beclomethasone; Double-Blind Method; Drug Resistance; Fenoterol; Humans; Respiratory Function Tests | 1992 |
Increased inhaled bronchodilator vs increased inhaled corticosteroid in the control of moderate asthma.
Topics: Administration, Inhalation; Adult; Aerosols; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Circadian Rhythm; Double-Blind Method; Drug Administration Schedule; Fenoterol; Humans; Peak Expiratory Flow Rate; Prednisone; Pregnenediones; Terbutaline | 1992 |
Salbutamol plus beclomethasone dipropionate (Ventolin Flogo) vs. fenoterol (Dosberotec) in chronic obstructive lung disease therapeutic strategy: a 4-week clinical trial.
Topics: Aged; Albuterol; Beclomethasone; Clinical Trials as Topic; Drug Combinations; Ethanolamines; Fenoterol; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Middle Aged; Time Factors | 1985 |
8 other study(ies) available for berotek and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Fatal asthma in a young patient with severe bronchial hyperresponsiveness but stable peak flow records.
Topics: Adolescent; Asthma; Beclomethasone; Bronchi; Death, Sudden; Fenoterol; Humans; Male | 1989 |
Fixed dose combination therapy in the treatment of asthma--the case against it.
Topics: Aerosols; Albuterol; Asthma; Beclomethasone; Bronchodilator Agents; Drug Combinations; Fenoterol; Humans; Ipratropium | 1988 |
[Effect of Berotec, Atrovent and Becotide on histamine-induced bronchial spasm in patients with chronic bronchitis].
Topics: Adult; Atropine Derivatives; Beclomethasone; Bronchi; Bronchial Provocation Tests; Bronchial Spasm; Bronchitis; Chronic Disease; Ethanolamines; Fenoterol; Histamine; Histamine Antagonists; Humans; Ipratropium; Male; Middle Aged | 1983 |
Clinical use of dry powder systems.
Topics: Albuterol; Asthma; Beclomethasone; Fenoterol; Humans; Powders; Respiratory Therapy | 1982 |
Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.
Topics: Administration, Inhalation; Administration, Topical; Adolescent; Adrenergic beta-Agonists; Adult; Aerosols; Albuterol; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Child; Child, Preschool; Drug Prescriptions; Drug Utilization Review; Fenoterol; Fluocinolone Acetonide; Glucocorticoids; Humans; Isoproterenol; Metaproterenol; Middle Aged; Pregnenediones; Procaterol; Saskatchewan; Triamcinolone | 1995 |
[Comparison of beta-2-agonist and beclomethasone effects on potassium levels, heart action and pulmonary ventilation parameters in patients with chronic asthmatic bronchitis].
Topics: Asthma; Beclomethasone; Bronchitis; Chronic Disease; Female; Fenoterol; Forced Expiratory Volume; Heart; Humans; Male; Middle Aged; Potassium; Respiratory Function Tests | 1993 |
Paradoxical bronchospasm and cutaneous rash after metered-dose inhaled bronchodilators.
Topics: Aerosols; Albuterol; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Spasm; Bronchodilator Agents; Drug Eruptions; Excipients; Female; Fenoterol; Glycine max; Humans; Ipratropium; Laryngismus; Middle Aged; Nebulizers and Vaporizers | 1996 |
Baseline airway hyperresponsiveness and its reversible component: role of airway inflammation and airway calibre.
Topics: Administration, Inhalation; Adult; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchial Hyperreactivity; Bronchial Provocation Tests; Female; Fenoterol; Forced Expiratory Volume; Humans; Male; Methacholine Chloride; Nitric Oxide; Sputum | 2000 |